Evidence map›Paper›PMID 28105373›Full record

ArticleInternational journal of retina and vitreous2017

Vascular changes on fluorescein angiography of premature infants with low risk of retinopathy of prematurity after high oxygen exposure.

Maria Ana Martinez-Castellanos, Raul Velez-Montoya, Kenneth Price, Andree Henaine-Berra, Gerardo García-Aguirre, Virgilio Morales-Canton, Linda Alejandra Cernichiaro-Espinosa

Open access · goldAbstract read
In one paragraph

Article in International journal of retina and vitreous, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. A proposal of an algorithm for the diagnosis and treatment of recurrence or treatment failure of retinopathy of prematurity after anti-VEGF therapy based on a large case series.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2020
    Article
  7. Aggressive posterior retinopathy of prematurity in two cohorts of patients in South India: implications for primary, secondary, and tertiary prevention.Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2019
    Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Maria Ana Martinez-CastellanosRetinal Department, Asociación para Evitar la Ceguera en Mexico, "Hospital Luis Sanchez Bulnes", IAP, Vicente Garcia Torres No. 46 Coyoacán, 04030 Mexico City, D.F. Mexico.
Raul Velez-MontoyaRetinal Department, Asociación para Evitar la Ceguera en Mexico, "Hospital Luis Sanchez Bulnes", IAP, Vicente Garcia Torres No. 46 Coyoacán, 04030 Mexico City, D.F. Mexico.
Kenneth PriceNew York University School of Medicine, New York University, New York, NY 10012 USA.
Andree Henaine-BerraRetinal Department, Asociación para Evitar la Ceguera en Mexico, "Hospital Luis Sanchez Bulnes", IAP, Vicente Garcia Torres No. 46 Coyoacán, 04030 Mexico City, D.F. Mexico.
Gerardo García-AguirreRetinal Department, Asociación para Evitar la Ceguera en Mexico, "Hospital Luis Sanchez Bulnes", IAP, Vicente Garcia Torres No. 46 Coyoacán, 04030 Mexico City, D.F. Mexico.
Virgilio Morales-CantonRetinal Department, Asociación para Evitar la Ceguera en Mexico, "Hospital Luis Sanchez Bulnes", IAP, Vicente Garcia Torres No. 46 Coyoacán, 04030 Mexico City, D.F. Mexico.
Linda Alejandra Cernichiaro-EspinosaRetinal Department, Asociación para Evitar la Ceguera en Mexico, "Hospital Luis Sanchez Bulnes", IAP, Vicente Garcia Torres No. 46 Coyoacán, 04030 Mexico City, D.F. Mexico.
Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes · MXNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo describe a wide array of peripheral vascular changes using fluorescein angiography in preterm neonates, without high risk characteristics for developing retinopathy of prematurity, that were exposed to high oxygen concentration.

methodsRetrospective, two center, case series. Newborns at two different hospitals with ≥1500 g or gestational age of ≥32 weeks, fluorescein angiography performed, and with high oxygen exposure without adequate control were included.

results294 infants diagnosed with ROP were analyzed. Only 28 eyes from 14 patients with peripheral vascular abnormalities in older and heavier babies were included. Two distinct type of peripheral vascular changes were observed: group 1 or non-proliferative: areas of capillary non-perfusion along with widespread arteriovenous shunting between adjacent primary vessels, tortuosity of primary vessels, abnormal budding of tertiary vessels and capillaries, abnormal capillary tufts and absence of foveal avascular zone; group 2 or proliferative: all of the characteristics of group 1 plus leakage of dye from the boundary between perfused and non-perfused retina and/or optic disc.

conclusionPeripheral vascular abnormalities different from retinopathy of prematurity are observed in older than 32 weeks of gestational age, and heavier than 1500 g babies. This makes the authors classify these patients as having a disease caused solely by oxygen dysregulation at the neonatal intensive care unit similarly to the oxygen induced retinopathy in experimental studies.

Indexed as

AngiographyOxygenRetinopathy of prematurityToxicityVasculogenesis

Identifiers

PMID28105373
PMCPMC5238517
OpenAlexW2561863836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.